title: Hepatotoxicity induced by horse ATG and reversed by rabbit ATG: a case report.
abstract: BACKGROUND
  The use of antilymphocyte agents has improved patient and graft survival in hematopoietic stem cell and solid organ transplantation but has been associated with the development of short-term toxicities as well as long-term complications.
  
  
  METHODS
  We report a young female with Fanconi anemia who received antithymocyte globulin as part of the conditioning regimen prior to her planned allogeneic hematopoietic stem cell transplant at King Faisal Specialist Hospital and Research Centre in Riyadh. She developed sudden and severe hepatotoxicity after receiving the first dose of horse antithymocyte globulin, manifested by marked elevation of serum transaminases and mild elevation of serum bilirubin level. Immediately after withdrawal of the offending agent and shifting to the rabbit form of antithymocyte globulin, the gross liver dysfunction started to subside and the hepatic profile results returned to the pre-transplant levels few weeks later. The patient had her allogeneic hematopoietic stem cell transplant as planned without any further hepatic complications. After having a successful allograft, she was discharged from the stem cell transplant unit. During her follow up at the outpatient clinic, the patient remained very well and no major complication was encountered.
  
  
  CONCLUSIONS
  Hepatotoxicity related to the utilization of antithymocyte globulin varies considerably in severity and may be transient or long standing. There may be individual or population based susceptibilities to the development of side effects and these adverse reactions may also vary with the choice of the agent used. Encountering adverse effects with one type of antithymocyte agents should not discourage clinicians from shifting to another type in situations where continuation of the drug is vital.
authors.affiliation: Section of Adult Hematology and Hematopoietic Stem Cell Transplant, King Faisal Cancer Centre, King Faisal Specialist Hospital and Research Centre, P,O, Box: 3354, Riyadh 11211, Saudi Arabia. khalid_alanazi@yahoo.com.
authors.forename: Khalid A
authors.initials: KA
authors.lastname: Al-Anazi
authors.forename: Mahmoud D
authors.initials: MD
authors.lastname: Aljurf
authors.forename: Fahad Z
authors.initials: FZ
authors.lastname: Al-Sharif
authors.forename: Hamad M
authors.initials: HM
authors.lastname: Al-Omar
authors.forename: Ahmed
authors.initials: A
authors.lastname: Alami
authors.forename: Fayyaz
authors.initials: F
authors.lastname: Farooq